Veszprém, Hungary

András Komáromi

This inventor holds 1 USPTO granted patent. Top assignee: Biorex Kutato Es Fejleszto Rt. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: András Komáromi. Retrieved from https://idiyas.com/inventor/andrandaacutes-komandaacuteromi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 15.0

ph-index = 1

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of András Komáromi

Introduction

András Komáromi is a notable inventor based in Veszprém, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of insulin resistance. His innovative work has led to the development of a unique patent that addresses critical health issues.

Latest Patents

András Komáromi holds a patent for N-[2-hydroxy-3-(1-piperidinyl)propoxy]pyridine-1-oxide-3-carboximidoyl chloride and its use in the treatment of insulin resistance. This patent encompasses various aspects, including its stereoisomers, pharmaceutical compositions, and methods for treating pathological insulin resistance. His work also focuses on addressing diabetes-induced chronic complications, such as retinopathy, neuropathy, and nephropathy, while promoting peripheral neuroregeneration.

Career Highlights

András Komáromi is associated with Biorex Kutato Es Fejleszto Rt, where he continues to advance his research and development efforts. His dedication to innovation in the pharmaceutical industry has positioned him as a key figure in addressing significant health challenges.

Collaborations

András has collaborated with notable colleagues, including Maria Kürthy and Katalin Bíró. Their combined expertise contributes to the advancement of research and development in their field.

Conclusion

András Komáromi's contributions to the treatment of insulin resistance through his innovative patent highlight his importance in the pharmaceutical industry. His work not only addresses critical health issues but also showcases the potential for future advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…